Clinical cure induced by pegylated interferon α-2b in the advantaged population of chronic hepatitis B virus infection: a retrospective cohort study

Clinical cure induced by pegylated interferon α-2b in the advantaged population of chronic hepatitis B virus infection: a retrospective cohort study

BackgroundAmong the advantaged population with clinical cure of chronic hepatitis B, chronic inactive hepatitis B virus carriers (IHCs) and nucleoside analog-experienced patients have similar serological manifestations. This study established non-interferon-treated groups as controls to compare the...

Full description

Bibliographic Details
Main Authors: Chaojing Wen, Yixuan Wang, Haoyue Tian, Yu Lei, Zhiyi Wang, Dachuan Cai, Zhi Zhou, Xiaofeng Shi
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-01-01
Series:Frontiers in Cellular and Infection Microbiology
Subjects:
clinical cure
chronic inactive hepatitis B virus carriers
nucleoside analog-experienced patients
HBsAg clearance
HBsAg seroconversion
pegylated interferon α-2b
Online Access:https://www.frontiersin.org/articles/10.3389/fcimb.2023.1332232/full

Internet

https://www.frontiersin.org/articles/10.3389/fcimb.2023.1332232/full

Similar Items